×
Hero Background

Antiemetics Companies

ID: MRFR/HC/6982-HCR
110 Pages
Rahul Gotadki
October 2025

Antiemetics are medications designed to prevent or alleviate nausea and vomiting. These drugs are commonly used in various medical conditions, including chemotherapy-induced nausea, postoperative nausea, and motion sickness.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Antiemetics Market Research Report - Global Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Antiemetics Market

Antiemetics Key Companies

 


Latest Antiemetics Companies Update:

Evoke Pharma's Exclusivity: In April 2022, Evoke Pharma received three-year exclusivity for Gimoti (metoclopramide) nasal spray, providing them a competitive edge in the oral alternative drug segment.


Acacia Pharmaceutical's FDA Approval: Barhemsys, Acacia Pharmaceutical's antiemetic, received US-FDA approval in February 2022, expanding their product portfolio and addressing a niche market for nausea and vomiting associated with migraine.


Pfizer's Transdermal Patch Development: In September 2023, Pfizer partnered with Relief Therapeutics to develop a transdermal patch for Aprepitant (Emend), aiming to improve patient compliance and ease of administration for chemotherapy-induced nausea and vomiting.


Meda Pharmaceuticals' Expansion: Meda Pharmaceuticals acquired Australian pharmaceutical company, Almirall, in January 2023, strengthening their market presence in antiemetics with Almirall's innovative NKTR-105.


List of Antiemetics Key companies in the market

  • GSK (UK)

  • Merck (US)

  • Sanofi-Aventis (France)

  • Pfizer Inc. (US)

  • Mylan (US)

  • Eli Lilly and Company (US)

  • Johnson & Johnson (US)

  • Baxter International (US)

  • Reddy's Laboratories Inc. (India)